DHB — Delivra Health Brands Income Statement
0.000.00%
Last trade - 00:00
- CA$12.50m
- CA$11.42m
- CA$9.79m
- 32
- 51
- 90
- 59
R2019 June 30th | R2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.98 | 7.78 | 7.96 | 8.14 | 9.79 |
Cost of Revenue | |||||
Gross Profit | 2.02 | 1.52 | 2.91 | 3.38 | 5.22 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 32.3 | 65 | 29.8 | 14.3 | 10.3 |
Operating Profit | -26.3 | -57.2 | -21.9 | -6.18 | -0.467 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -26.2 | -58.7 | -22.7 | -7.01 | -0.184 |
Net Income After Taxes | -26.2 | -58.7 | -22.7 | -7.01 | -0.184 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -27.9 | -79.9 | -28.5 | -7.01 | -0.184 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -27.9 | -79.9 | -28.5 | -7.01 | -0.184 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.1 | -0.067 | -0.039 | -0.021 | -0.005 |